RUSSO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 16.542
AS - Asia 6.723
NA - Nord America 4.945
SA - Sud America 1.344
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AN - Antartide 1
Totale 29.654
Nazione #
RU - Federazione Russa 12.224
US - Stati Uniti d'America 4.821
SG - Singapore 2.524
IE - Irlanda 1.580
CN - Cina 1.530
HK - Hong Kong 1.350
BR - Brasile 1.130
IT - Italia 520
GB - Regno Unito 502
DE - Germania 491
FR - Francia 391
VN - Vietnam 376
KR - Corea 345
UA - Ucraina 247
IN - India 195
SE - Svezia 148
GR - Grecia 122
AR - Argentina 98
FI - Finlandia 96
JP - Giappone 67
AT - Austria 63
TR - Turchia 63
CA - Canada 53
MX - Messico 40
BD - Bangladesh 38
ID - Indonesia 38
EC - Ecuador 37
AE - Emirati Arabi Uniti 36
IQ - Iraq 27
CZ - Repubblica Ceca 26
NL - Olanda 26
PL - Polonia 26
BE - Belgio 23
ZA - Sudafrica 22
PY - Paraguay 19
PK - Pakistan 18
SA - Arabia Saudita 18
UZ - Uzbekistan 17
MA - Marocco 15
CO - Colombia 13
EG - Egitto 13
VE - Venezuela 13
ES - Italia 11
JO - Giordania 10
PE - Perù 10
CL - Cile 9
DO - Repubblica Dominicana 8
LB - Libano 8
UY - Uruguay 8
LT - Lituania 7
AL - Albania 6
BO - Bolivia 6
ET - Etiopia 6
KE - Kenya 6
OM - Oman 6
RO - Romania 6
DZ - Algeria 5
IL - Israele 5
JM - Giamaica 5
NP - Nepal 5
PT - Portogallo 5
SN - Senegal 5
TN - Tunisia 5
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
HN - Honduras 4
IR - Iran 4
MY - Malesia 4
PA - Panama 4
PS - Palestinian Territory 4
QA - Qatar 4
AM - Armenia 3
BH - Bahrain 3
CH - Svizzera 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NI - Nicaragua 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AQ - Antartide 1
BB - Barbados 1
CR - Costa Rica 1
DK - Danimarca 1
Totale 29.643
Città #
Moscow 4.288
Dublin 1.579
Hong Kong 1.342
Santa Clara 1.112
Singapore 941
Chandler 506
Jacksonville 461
Hefei 381
Seoul 344
Princeton 228
The Dalles 209
Dallas 201
Roxbury 190
Bengaluru 157
Ho Chi Minh City 154
Ashburn 143
Beijing 139
Bremen 130
Medford 123
Cambridge 114
São Paulo 95
Munich 91
Naples 78
Ann Arbor 74
Wilmington 70
Boardman 67
Nuremberg 63
Hanoi 61
New York 50
Des Moines 48
San Mateo 48
Los Angeles 46
Falkenstein 38
Woodbridge 34
Belo Horizonte 33
Caserta 33
Rio de Janeiro 27
Vienna 27
Guangzhou 26
Jinan 26
Brussels 23
Changsha 22
Tianjin 21
Aversa 20
Brno 20
Da Nang 19
London 19
Guarulhos 18
Shenyang 18
Stockholm 18
Brooklyn 17
Lappeenranta 17
Mexico City 17
Rome 17
Turku 17
Warsaw 17
Curitiba 16
Zhengzhou 16
Porto Alegre 15
Tashkent 15
Columbus 14
Council Bluffs 14
Hangzhou 14
Houston 14
Lusciano 14
Nanchang 14
Nanjing 14
San Francisco 14
Shanghai 14
Tokyo 14
Atlanta 13
Haiphong 13
Milan 13
Boston 12
Brasília 12
Dhaka 12
Düsseldorf 12
Ercolano 12
Guayaquil 12
Helsinki 12
Norwalk 12
Quito 12
Salvador 12
Toronto 12
Afragola 11
Amsterdam 11
Florence 11
Manchester 11
Marano Di Napoli 11
Napoli 11
Amman 10
Chicago 10
Hebei 10
Johannesburg 10
Montreal 10
Volta Redonda 10
Baghdad 9
Campinas 9
Chennai 9
Frankfurt am Main 9
Totale 14.612
Nome #
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 155
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 154
Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. 150
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 146
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 140
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 139
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 138
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 137
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 137
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 136
Acute myocarditis: prognostic role of speckle tracking echocardiography and comparison with cardiac magnetic resonance features 135
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 133
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 132
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation 130
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 130
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 130
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 130
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 130
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 129
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 129
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 128
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients 128
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 127
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 126
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 125
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 124
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 124
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 124
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 123
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 123
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 123
Coronary sinus spasm during left ventricular lead implantation for biventricular pacing 122
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 122
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 121
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 121
Sympathovagal balance analysis in idiopathic postural orthostatic tachycardia syndrome. 120
A Systematic Review and Meta-analysis of the Association Between Implantable Cardioverter-Defibrillator Shocks and Long-term Mortality 119
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders 119
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 118
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 118
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 117
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 116
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 115
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study 115
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 114
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 114
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 113
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 113
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 112
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 111
Myocardial Work Efficiency in Physiologic Left Ventricular Hypertrophy of Power Athletes 110
Air entrapment as a cause of S-ICD inappropriate shocks 110
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 110
Superior vena cava thrombosis after intravascular AICD lead extraction: a case report 110
Biventricular pacing and heterogeneity of ventricular repolarization in heart failure patients 110
Anti-arrhythmic properties of non-antiarrhythmic medications 110
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 109
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 109
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 107
Effects of High Intensity Interval Training Rehabilitation Protocol after an Acute Coronary Syndrome on Myocardial Work and Atrial Strain 107
Giant coronary sinus in patient with double superior vena cava demonstrated by multislice computed tomography 106
Vasovagal Syncope at Work: A Narrative Review for an Occupational Management Proposal 105
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 105
Asystole on loop recorder in patients with unexplained syncope and negative tilt testing: age distribution and clinical predictors 104
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation 104
Echocardiography in Cardiac Arrest: Incremental Diagnostic and Prognostic Role during Resuscitation Care 104
Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. 104
Smartphone and new tools for Atrial Fibrillation diagnosis: evidence for clinical applicability 104
COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden 103
Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry 103
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 103
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 102
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 101
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study 101
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 100
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 100
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 100
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors 100
Remote monitoring of implantable cardiac monitors in patients with unexplained syncope: Predictors of false‐positive alert episodes 99
Put out the fire: The pleiotropic anti-inflammatory action of non-vitamin K oral anticoagulants 99
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 98
TAKOTSUBO CARDIOMYOPATHY AS EPIPHENOMENON OF CARDIOTOXICITY IN CANCER PATIENTS: A META SUMMARY OF CASE REPORTS 98
Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management 97
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 97
Autonomic nervous system modulation before the onset of sustained atrioventricular nodal reentry tachycardia. 97
Anti-arrhythmic therapy in patients with non-ischemic cardiomyopathy 97
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients 96
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 96
Brugada syndrome and COVID-19 vaccines 96
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 95
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 95
Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis 95
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response 94
Heart rate variability, obesity, and bariatric-induced weight loss: the importance of selection criteria 94
Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry 94
Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report. 93
Superselective cannulation of coronary sinus branch with telescopic system during left ventricular lead placement 93
Prevalence and clinical predictors of vasodepressor syncope during head up tilt test 92
Atrial Fibrillation and Mitral Regurgitation: Clinical Performance of Direct Oral Anticoagulants in a Real-World Setting 92
Cardiovascular comorbidities and pharmacological treatments of covid-19 patients not requiring hospitalization 92
Totale 11.375
Categoria #
all - tutte 101.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021468 0 0 0 0 0 10 122 57 13 72 166 28
2021/20221.401 51 18 34 46 395 4 8 33 39 145 199 429
2022/20232.500 256 29 38 180 235 172 9 110 1.374 28 37 32
2023/20241.110 70 39 50 64 448 51 44 19 11 29 78 207
2024/20255.241 30 46 19 68 752 664 447 447 757 1.086 452 473
2025/202617.802 915 1.133 1.331 1.212 1.699 11.512 0 0 0 0 0 0
Totale 30.213